Oct 2 (Reuters) - Summit Therapeutics on Friday announced a clinical trial collaboration with AstraZeneca and Daiichi Sankyo ...

A deep dive into what Carnegie Mellon's Miami campus could mean for the local economy, pharma giant AstraZeneca will invest ...

The firms will begin their collaboration with a Phase 3 study of Ivonescimab in combination with Datroway in first-line ...

AstraZeneca and Daiichi Sankyo have partnered with Summit Therapeutics to explore the potential of their co-developed antibody-drug conjugate (ADC), Datroway (datopotamab deruxtec ...

AstraZeneca has promoted Maciej Szymaszek, PhD, MBA, PMP, to Head of Commercial AI Strategy, Innovation and Business ...

United Immunity entered into a master clinical supply agreement with Roche to evaluate UI-102 in combination with an ...

Daiichi Sankyo (4568.TS) and AstraZeneca (AZN) have entered into a clinical trial collaboration agreement with Summit Therapeutics (SMMT) to evaluate Datroway (datopotamab deruxtecan) in combination ...

AstraZeneca PLC (NASDAQ:AZN) said on September 28 that it will make a $2 billion equity investment in Summit Therapeutics, ...

Roughly 700,000 seniors have started GLP-1 obesity treatments since Medicare’s Bridge program launched July 1, 2026, ...

AstraZeneca just locked in a price to own 12% of Summit Therapeutics that the open market refuses to match, and two clinical ...

The European Commission has revoked the EU marketing authorization for Hansoh Pharma’s lung cancer drug Aumseqa (aumolertinib ...

Summit Therapeutics scores a $2 billion equity investment from AstraZeneca to support ivonescimab’s late-stage development; ...